Stay updated on Lanabecestat in Early Alzheimer's Disease Clinical Trial
Sign up to get notified when there's something new on the Lanabecestat in Early Alzheimer's Disease Clinical Trial page.

Latest updates to the Lanabecestat in Early Alzheimer's Disease Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.5%
- Check32 days agoChange DetectedThe web page has been updated to reflect a new version (v2.14.2) of the NLM-NCBI services and products, along with a notice about potential performance issues due to heavy traffic.SummaryDifference0.6%
- Check41 days agoChange DetectedA new study on the efficacy and safety of LY3314814 in early Alzheimer's disease has been added, providing more information for interested users.SummaryDifference0.3%
- Check49 days agoChange DetectedThe website has been updated from version v2.14.0 to v2.14.1.SummaryDifference0.0%
- Check56 days agoChange DetectedThe link to the study on the efficacy and safety of LY3314814 in early Alzheimer's disease has been removed.SummaryDifference0.3%
- Check63 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.1%
Stay in the know with updates to Lanabecestat in Early Alzheimer's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lanabecestat in Early Alzheimer's Disease Clinical Trial page.